topSkip to main content

Menu, Secondary

Menu Trigger


University of Rochester

The University of California San Diego has joined a Phase II clinical trial to evaluate various additional COVID-19 booster shots. The trial seeks to understand if different vaccine regimens can broaden immune responses in adults who already have received a primary vaccination series and a first booster shot.
Research from University of Rochester documents for the first time the pollution of public water supplies caused by shale gas development, commonly known as fracking, and its negative impact of infant health. 
A new grant will enable biologists at Rochester, Brown, and New York University to explore potential targets of treatments and therapeutics for neurodegenerative diseases.
Scientists at University of Rochester and University of Maryland report progress in targeting and destroying leukemic stem cells with a modified form of micheliolide, a natural product found in plants of the magnolia family.
Rochester undergraduates have developed a fast, noninvasive, affordable, and eco-friendly way to diagnose sepsis, a life-threatening medical complication.
Rochester psychologists make the case for an approach to FASD based on patients’ strengths rather than deficits.
Scientists at the University of Rochester are rapidly adapting previous research to develop tests to detect the fast-spreading disease.
The University of Rochester Medical Center (URMC) is participating in a NIH-sponsored clinical trial to evaluate the safety and efficacy of the investigational antiviral drug remdesivir in hospitalized adults diagnosed with COVID-19
Mical Raz, a University of Rochester health policy expert, physician, and historian, says implementing the most up-to-date understanding of epidemiology is key to dealing effectively with pandemics like coronavirus.
University of Rochester biology professors studied naked mole rats to see if the rodents exhibit an anticancer mechanism called cellular senescence.